Edition:
United States

Biotechnology & Medical Research

Page 1

Replicel Life Sciences continues restructuring with share structure consolidation

Friday, 22 Jul 2016 09:20pm EDT

Replicel Life Sciences Inc : Replicel Life Sciences continues restructuring with share structure consolidation .Says its board of directors has authorized a plan to proceed with a consolidation of its outstanding common shares.

Replicel Life Sciences continues restructuring with share structure consolidation

Friday, 22 Jul 2016 07:05pm EDT

Replicel Life Sciences Inc : Replicel Life Sciences continues restructuring with share structure consolidation .Says its board of directors has authorized a plan to proceed with a consolidation of its outstanding common shares.

VBI Vaccines files for mixed shelf of upto $150 mln

Friday, 22 Jul 2016 04:33pm EDT

Vbi Vaccines Inc :VBI Vaccines Inc files for mixed shelf of upto $150 million - SEC filing.

Richard Schottenfeld reports 5.4 pct stake in Neptune Technologies & Bioressources

Friday, 22 Jul 2016 04:10pm EDT

Neptune Technologies & Bioressources Inc : Richard Schottenfeld Reports 5.4 Pct Stake In Neptune Technologies & Bioressources Inc As Of July 12 - SEC filing .Acquired shares of Neptune Technologies common stock believing that such shares of common stock were undervalued.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.